about
Substantial contribution of extrinsic risk factors to cancer developmentHomologous-recombination-deficient tumours are dependent on Polθ-mediated repairThe Cancer Genome Atlas Pan-Cancer analysis projectPD-L1 expression in human cancers and its association with clinical outcomesDNA damage, tumor mutational load and their impact on immune responses against cancerTowards tumor immunodiagnosticsNeoantigen-based cancer immunotherapySignaling Pathways in MelanogenesisImmunotherapy for head and neck squamous cell carcinomaTargeting DNA Replication Stress for Cancer TherapyNew targeted treatments for non-small-cell lung cancer - role of nivolumabDNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and BeyondProtein oxidation, UVA and human DNA repairModern Radiotherapy Concepts and the Impact of Radiation on Immune ActivationTranslational Research to Improve the Efficacy of Carbon Ion Radiotherapy: Experience of Gunma UniversityLong noncoding RNAs in cancer: mechanisms of action and technological advancementsThe immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpointsImmunotherapy for lung cancerClinical utility of nivolumab in the treatment of advanced melanomaRoles for retrotransposon insertions in human diseaseCancer immunotherapy: the beginning of the end of cancer?The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutationsQuantitative Trait Loci Identify Functional Noncoding Variation in CancerGenetics and biology of pancreatic ductal adenocarcinomaMechanisms underlying structural variant formation in genomic disordersCancer Evolution-Development: experience of hepatitis B virus-induced hepatocarcinogenesisCancer Evolution and the Limits of Predictability in Precision Cancer MedicinePD-1/PD-L1 blockade in cancer treatment: perspectives and issuesMutations, kataegis and translocations in B cells: understanding AID promiscuous activityMutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor VaccinationTranslating cancer genomes and transcriptomes for precision oncologyNovel immunotherapies in lymphoid malignanciesRevealing the Complexity of Breast Cancer by Next Generation SequencingGenomics of Cancer and a New Era for Cancer PreventionExploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer ImmunotherapyRadio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical ApplicationsCan Peto's paradox be used as the null hypothesis to identify the role of evolution in natural resistance to cancer? A critical reviewBig Data: the challenge for small research groups in the era of cancer genomicsThe influence of subclonal resistance mutations on targeted cancer therapyAssociations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review)
P2860
Q22251076-7A90B616-8944-40CA-942F-4701C0C5756CQ24317107-D4D04327-6114-44C1-B89A-F960867BE87CQ24606808-59182335-617C-4F3B-A5EB-D8D2C823A775Q26738361-9A16F966-6FBD-4F7D-B192-1A4CED76E8F1Q26738685-359EDD7C-F6C8-41F3-BC11-22EEF3000C73Q26738691-837D5182-9A19-4E66-8C42-2BABFFD548A1Q26738693-8AFE16FE-02B5-4905-9EE2-2B7374F3D10CQ26739678-6C5C0516-2404-447F-9DD2-3FCF94014EDAQ26739850-CEFB5E7E-4873-4062-978F-221D62A32B24Q26739923-845EED91-997E-4313-80BA-F3C0944722F4Q26740988-37331CF4-BF32-4F13-B20E-C51A06965C06Q26743371-3DE566FF-75CF-47DA-A806-08DE5F646A8CQ26744266-88CBAC2D-E6A3-4DF3-80E8-75A541CB8A4FQ26744490-C3AF9F9F-EE48-4B2E-B18F-E62B4BA18E12Q26744799-9D3300B9-5ADE-4CFA-AF8E-A18A945B8143Q26745528-C53915AD-48BD-4C6B-8774-540E854D7936Q26745842-79472725-A4DD-4531-A16F-9CB85E9D60D2Q26751254-C527B7EC-1B87-4610-AD00-6CCC2467D58DQ26751268-DBC789CB-B41B-4A09-8715-8F3BBA4E9292Q26751314-931E6205-40F9-44D2-AE3C-D5984A40190BQ26752277-FD665C4A-4845-4354-9D7A-796B1F431176Q26753387-98599939-0016-499F-B178-3B8D38F942C5Q26764745-07ED023E-7B62-44F6-BDE4-85A1247A2DCAQ26765438-1AAC1DD4-6655-47D8-9E07-66F7AC6F5BE8Q26765934-182E901A-E54F-4C1E-AC7A-B267D4BEFEEAQ26766386-3B83B197-F301-48A9-8281-460002F78946Q26767415-84A8CE90-8EE8-4590-9292-1B1BE4494EBBQ26768641-039C3E48-E96B-43D4-A4FF-82AD5E25FA94Q26768663-80DCB754-EDC4-43A8-A89D-8ABC9DB428A4Q26769044-E807EA0E-0DFB-485D-8463-C5F3FDF8C6DAQ26777081-BCF4F806-9685-4D40-BE16-3A0B02C93A7DQ26777394-BAECF5FF-D876-4B67-A992-77BDCAB35781Q26777395-1C35C3FA-B6F8-48AB-ACA6-183C48A82B47Q26779113-584D4F14-20CC-4AE0-AA33-775657E9E681Q26779184-F1939F83-8AC3-45BF-AA6A-E086C90BBF5DQ26779221-9ECA7DF6-B936-43FF-9141-48D325A95E71Q26779417-1238E6A3-69EF-4514-8561-8D2AD0622294Q26780460-49B2AC22-ED40-4250-9A93-445329E98133Q26781693-3BD3EB60-353A-478D-99BA-BF7DCD38E25DQ26781812-CCF725C4-9649-47C5-A5F7-C7A6A0D96C0A
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Signatures of mutational processes in human cancer
@ast
Signatures of mutational processes in human cancer
@en
type
label
Signatures of mutational processes in human cancer
@ast
Signatures of mutational processes in human cancer
@en
prefLabel
Signatures of mutational processes in human cancer
@ast
Signatures of mutational processes in human cancer
@en
P2093
P2860
P50
P3181
P356
P1433
P1476
Signatures of mutational processes in human cancer
@en
P2093
Alexandrov LB
Aparicio SA
Biankin AV
Bignell GR
Burkhardt B
P2860
P2888
P304
P3181
P356
10.1038/NATURE12477
P407
P50
P577
2013-08-22T00:00:00Z
P5875
P6179
1050004918